The hospital acquired infection control market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19. The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.
Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing and limited reimbursement in developing countries and end-user noncompliance with sterilization standards, is expected to restrain the growth of this market.
To know about the assumptions considered for the study download the pdf brochure
The global hospital acquired infection control market is consolidated at the top, with many leading market players based in developed countries. The prominent players in this market are STERIS plc (US), Sotera Health Company (US), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (US), Ecolab Inc. (US), 3M Company (US), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (UK), Metrex Research LLC (UK), Miele Group (Germany), Pal International (UK), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (US), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (US), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany). However, several smaller players have emerged from niche markets in the past few years, competing with global players based on price and service offering. Due to intense competition in the market, major market players increasingly focus on expanding their geographic presence into high-growth emerging markets and strengthening their technological competitiveness by acquiring smaller players with the desired technological capabilities or geographical presence.
STERIS plc is a leading company in the sterilization services industry and is a leading provider of sterilization technologies and services. The company’s broad service portfolio is its key strength. STERIS markets an array of contract processing services using gamma irradiation, electron beam processing, and EtO technologies, along with a range of laboratory testing services. It also has a strong geographic presence across North America, Latin America, Europe, Asia, and the Middle East & Africa. The company derives most of its revenues from North America, specifically the US market. It dominates the sterilization products and services market and also has a significant position in the disinfectants market. To further expand and maintain its leading market position, STERIS focuses both on organic and inorganic strategies, such as acquisitions, and geographic expansions. In 2020, it announced the addition of X-ray services to its facilities in Thailand, adding to its existing gamma irradiation capacity.
Getinge AB holds a significant market position in both the sterilization products & services and disinfectants markets. Getinge has built an extensive product portfolio of infection control products. The company offers flusher disinfectors, washer-disinfectors, and cart washer-disinfectors in this market. It derives a majority of its revenue from the developed regions of North America and Europe. The US accounted for 33% of the Group’s sales and was the only country that accounted for more than 10% of total sales in 2020. The company has a diversified consumer base that includes hospitals, medical device & pharmaceutical companies, and universities. In June 2018, the company became one of the suppliers of Karolinska Institutet, a medical university in Sweden, having one of Europe’s largest laboratories. It focuses on organic and inorganic growth strategies, such as product launches, agreements, and acquisitions, which enable it to further strengthen its market position. In the last three years, Getinge has launched a number of products, such as steam sterilizers, washer-disinfectors, and biological indicators, in the market. These products offer procedure efficiency and low-processing time, aiding the overall sterilization or disinfection process. Also, in 2020, Getinge acquired Quadralene, a global manufacturer of decontamination products such as detergents and disinfectants for the healthcare and dental sectors, expanding Getinge’s product portfolio for disinfectant products.
Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers), COVID-19 Impact - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE